Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1887Carcinoma, Non-Small-Cell Lung 1346Prostatic Neoplasms 980Colorectal Neoplasms 851Multiple Myeloma 741Leukemia, Myeloid, Acute 725Neoplasms 690Lung Neoplasms 679Neoplasm Metastasis 642Lymphoma 579Carcinoma, Hepatocellular 571Pancreatic Neoplasms 566Stomach Neoplasms 522Leukemia 511Recurrence 492Leukemia, Lymphocytic, Chronic, B-Cell 459Precursor Cell Lymphoblastic Leukemia-Lymphoma 452Melanoma 451Lymphoma, Non-Hodgkin 442Ovarian Neoplasms 426Lymphoma, Large B-Cell, Diffuse 423Squamous Cell Carcinoma of Head and Neck 416Myelodysplastic Syndromes 416Head and Neck Neoplasms 403Brain Neoplasms 402Rectal Neoplasms 396Glioblastoma 375Carcinoma, Renal Cell 349Hodgkin Disease 338Lymphoma, Follicular 336

Interventions

bismuth tripotassium dicitrate 1S 1 (combination) 1Oxaliplatin 1Omeprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Chemotherapy Effect × Clear all
NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡